Phillips-Medisize Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Phillips-Medisize Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7277
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Phillips-Medisize Corp (Phillips-Medisize) is a provider of outsourced design and manufacturing services to medical, defense, consumer, and automotive markets. The company operates as a subsidiary of Molex LLC. It offers a broad range of pre-production and production services. The company offers a range of drug delivery, medical device and diagnostic products, including glucose meters, disposable insulin pens, specialty inhalation drug delivery devices, single use surgical devices and consumable diagnostic components. Its major capabilities include design development, prototyping, plastic injection molding, metal injection molding (MIM), magnesium thixomolding, testing, secondary operations, multi-shot liquid silicone rubber, micro molding, sub and complete assembly. The company has manufacturing and design facilities in the US, Mexico, Finland, Switzerland, the Netherlands, Czech Republic, Ireland and China. Phillips-Medisize is headquartered in Hudson, Wisconsin, the US.

Phillips-Medisize Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Phillips-Medisize Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Phillips-Medisize Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Phillips-Medisize Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Phillips-Medisize Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Phillips-Medisize Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Phillips-Medisize Corp, Medical Equipment, Deal Details 12
Private Equity 12
Maj Invest Equity Acquires Remaining 35% Stake in Bang & Olufsen Medicom 12
Golden Gate Capital To Acquire Phillips-Medisize From Kohlberg 13
Partnerships 15
Bang & Olufsen Medicom Enters into Licensing Agreement with Pharma Company 15
Bang & Olufsen Medicom Enters Into Licensing Agreement With Pharma Company For Electronic Auto-Injector 16
Phillips-Medisize Partners with InterSystems 17
Dance Biopharm Enters into Co-Development Agreement with Phillips-Medisize 18
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company for Electronic Drug Delivery System 19
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company 20
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 21
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 22
Bang & Olufsen Medicom Enters into Co-Development Agreement with Pharma Company 23
Bang & Olufsen Medicom Enters Into Co-Development Agreement With Pharma Company For Electronic Auto-Injector 24
Acquisition 25
Flexicare Medical Acquires Medisize 25
Molex Acquires Phillips-Medisize 26
Phillips-Medisize Acquires Medicom Innovation Partner 27
Phillips-Medisize To Acquire Omni Manufacturing Services From Adval Tech 28
Phillips-Medisize To Acquire Adval Tech Medical (Suzhou) From Adval Tech 29
Phillips-Medisize Corp – Key Competitors 30
Phillips-Medisize Corp – Key Employees 31
Phillips-Medisize Corp – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 32
Recent Developments 33
Strategy And Business Planning 33
Oct 08, 2018: Phillips-Medisize partners with InterSystems in connected health platform 33
Aug 23, 2018: Phillips-medisize continues to attract industry thought leaders to connected health team 34
May 17, 2018: Phillips-Medisize Opens New Facility in China 35
May 01, 2018: Phillips-Medisize Expands and Adds Drug Handling Capability at New Richmond Facility 36
Jan 18, 2018: Phillips-Medisize Announces Expansion of Significant Medical Customer for Molex Little Rock Facility 37
Dec 06, 2017: Phillips-Medisize Creates a Manufacturing Center of Excellence for Connected Health and Drug Delivery Devices 38
Corporate Communications 39
May 17, 2018: Phillips-Medisize Opens New Facility in China 39
May 18, 2017: Phillips-Medisize Appoints Michael Ratigan 40
Feb 07, 2017: Phillips-Medisize Adds Dr. Robert Langer to Strategic Advisory Board 41
Product News 42
May 15, 2018: Phillips-Medisize Invites Visitors to Discuss Drug Delivery Partnerships at Innopack Pharma Confex India 42
Apr 13, 2018: Phillips-Medisize Invites Visitors to Discuss Connected Health During Medtec Europe 43
Nov 28, 2017: Phillips-Medisize Exhibits During DDL2017 44
Nov 02, 2017: Phillips-Medisize Presents on Next Generation Connected Drug Delivery Devices During PDA Conference 45
Oct 19, 2017: Phillips-Medisize Showcases Connected Drug Delivery Devices at InnoPack 46
Feb 01, 2017: Phillips-Medisize and Medicom Innovation Partner to Present at Drug Delivery Partnerships 2017 47
Jan 24, 2017: Phillips-Medisize Focuses on Connected Drug Delivery Devices for Improved Therapeutic Outcomes during Pharmapack, Paris 48
Other Significant Developments 49
Sep 26, 2018: Enhanced Capabilities Enable Phillips-Medisize to Better Serve Customers 49
Jul 24, 2018: Phillips-Medisize enhances integrated connected health platform 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Phillips-Medisize Corp, Medical Equipment, Key Facts 2
Phillips-Medisize Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Phillips-Medisize Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Phillips-Medisize Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Phillips-Medisize Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Phillips-Medisize Corp, Deals By Market, 2012 to YTD 2018 9
Phillips-Medisize Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Maj Invest Equity Acquires Remaining 35% Stake in Bang & Olufsen Medicom 12
Golden Gate Capital To Acquire Phillips-Medisize From Kohlberg 13
Bang & Olufsen Medicom Enters into Licensing Agreement with Pharma Company 15
Bang & Olufsen Medicom Enters Into Licensing Agreement With Pharma Company For Electronic Auto-Injector 16
Phillips-Medisize Partners with InterSystems 17
Dance Biopharm Enters into Co-Development Agreement with Phillips-Medisize 18
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company for Electronic Drug Delivery System 19
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company 20
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 21
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 22
Bang & Olufsen Medicom Enters into Co-Development Agreement with Pharma Company 23
Bang & Olufsen Medicom Enters Into Co-Development Agreement With Pharma Company For Electronic Auto-Injector 24
Flexicare Medical Acquires Medisize 25
Molex Acquires Phillips-Medisize 26
Phillips-Medisize Acquires Medicom Innovation Partner 27
Phillips-Medisize To Acquire Omni Manufacturing Services From Adval Tech 28
Phillips-Medisize To Acquire Adval Tech Medical (Suzhou) From Adval Tech 29
Phillips-Medisize Corp, Key Competitors 30
Phillips-Medisize Corp, Key Employees 31
Phillips-Medisize Corp, Other Locations 32
Phillips-Medisize Corp, Subsidiaries 32
Phillips-Medisize Corp, Joint Venture 32

List of Figures
Phillips-Medisize Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Phillips-Medisize Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Phillips-Medisize Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Phillips-Medisize Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Phillips-Medisize Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Phillips-Medisize Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Phillips-Medisize Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Phillips-Medisize Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Phillips-Medisize Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Scienion AG-医療機器分野:企業M&A・提携分析
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …
  • Bloomsbury Publishing Plc (BMY):企業の財務・戦略的SWOT分析
    Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ergomed Plc (ERGO):企業の財務・戦略的SWOT分析
    Summary Ergomed Plc (Ergomed) is a provider of drug development and clinical research services. The company offers clinical development, trial management, pharmacovigilance, medical monitoring and writing, project management and monitoring, regulatory affairs, quality, data and site management, clin …
  • China Aerospace Science and Industry Corp:戦略・SWOT・企業財務分析
    China Aerospace Science and Industry Corp - Strategy, SWOT and Corporate Finance Report Summary China Aerospace Science and Industry Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Malaysian Resources Corporation Berhad (MRCB):企業の財務・戦略的SWOT分析
    Malaysian Resources Corporation Berhad (MRCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Kymab Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kymab Ltd (Kymab) is a therapeutic antibody company that provides drug and vaccine development solutions. The company offers pipepline of assets in the therapeutic areas of immuno-oncology, inflammatory disease, haematology, and infectious diseases. Its pipeline products includes KY1003-Anti …
  • Kaneka Corp (4118):企業の財務・戦略的SWOT分析
    Kaneka Corp (4118) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Lietuvos energijos gamyba, AB (LNR1L)-エネルギー分野:企業M&A・提携分析
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • Synopsys Inc (SNPS):企業の財務・戦略的SWOT分析
    Synopsys Inc (SNPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cegid Group SA (CGD):企業の財務・戦略的SWOT分析
    Cegid Group SA (CGD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hyatt Hotels Corporation:企業のM&A・事業提携・投資動向
    Hyatt Hotels Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hyatt Hotels Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Loews Corp:企業の戦略・SWOT・財務情報
    Loews Corp - Strategy, SWOT and Corporate Finance Report Summary Loews Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Berg LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns o …
  • Network Rail Limited:企業の戦略・SWOT・財務分析
    Network Rail Limited - Strategy, SWOT and Corporate Finance Report Summary Network Rail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • InviCRO LLC:医療機器:M&Aディール及び事業提携情報
    Summary InviCRO LLC (InviCRO) a subsidiary of Konica Minolta Inc, is a provider of image informatics, engineering and operational services in translational drug discovery and development. The company developed VivoQuant, a DICOM compliant post-processing suite for image data combining fundamental vi …
  • Ternium SA:戦略・SWOT・企業財務分析
    Ternium SA - Strategy, SWOT and Corporate Finance Report Summary Ternium SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Filtronic plc:企業の戦略・SWOT・財務情報
    Filtronic plc - Strategy, SWOT and Corporate Finance Report Summary Filtronic plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Nature’s Bounty Co.:企業の戦略・SWOT・財務情報
    The Nature’s Bounty Co. - Strategy, SWOT and Corporate Finance Report Summary The Nature’s Bounty Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Evolution Mining Ltd:企業のM&A・事業提携・投資動向
    Evolution Mining Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evolution Mining Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • 4SC AG (VSC):製薬・医療:M&Aディール及び事業提携情報
    Summary 4SC AG (4SC) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of cancer and autoimmune diseases. The company’s product focuses on epigenetics, cancer stem cells and cancer immunotherapy. Its product pipeline comprises therapeutic programs at v …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆